Mirati Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Mirati Therapeutics, Inc.‘s stocks are currently a part of 243 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 57.00M shares of Mirati Therapeutics, Inc.. Compared to the previous quarter, the number grew by 0.29% or 164.73K shares more. As for the holding position changes, 39.09% (95) of current hedge fund investors increased the number of shares held, 28.4% (69) of current holders sold a part of the shares held, and 26.75% (65) closed the holdings completely. 58 hedge funds are new holders of Mirati Therapeutics, Inc. stock in Q1 2022, it is 23.87% of total holders.
Hedge funds holding Mirati Therapeutics (Q2 2017 – Q1 2022)
Q2 2017 | 49 |
---|---|
Q3 2017 | 49 |
Q4 2017 | 63 |
Q1 2018 | 81 |
Q2 2018 | 108 |
Q3 2018 | 125 |
Q4 2018 | 111 |
Q1 2019 | 155 |
Q2 2019 | 168 |
Q3 2019 | 173 |
Q4 2019 | 187 |
Q1 2020 | 172 |
Q2 2020 | 198 |
Q3 2020 | 223 |
Q4 2020 | 281 |
Q1 2021 | 259 |
Q2 2021 | 241 |
Q3 2021 | 235 |
Q4 2021 | 252 |
Q1 2022 | 243 |
Hedge funds changes in Mirati Therapeutics positions (Q2 2017 – Q1 2022)
Q2 2017 | 13 | 12 | 14 | 25 | -15 |
---|---|---|---|---|---|
Q3 2017 | 14 | 16 | 10 | 13 | -4 |
Q4 2017 | 27 | 20 | 12 | 13 | -9 |
Q1 2018 | 32 | 22 | 19 | 13 | -5 |
Q2 2018 | 54 | 29 | 17 | 26 | -18 |
Q3 2018 | 31 | 50 | 31 | 14 | -1 |
Q4 2018 | 20 | 48 | 31 | 33 | -21 |
Q1 2019 | 56 | 52 | 37 | 12 | -2 |
Q2 2019 | 45 | 63 | 40 | 28 | -8 |
Q3 2019 | 28 | 68 | 57 | 23 | -3 |
Q4 2019 | 47 | 68 | 61 | 28 | -17 |
Q1 2020 | 29 | 84 | 46 | 42 | -29 |
Q2 2020 | 45 | 85 | 49 | 18 | 1 |
Q3 2020 | 49 | 66 | 83 | 22 | 3 |
Q4 2020 | 79 | 101 | 80 | 21 | 0 |
Q1 2021 | 40 | 94 | 99 | 57 | -31 |
Q2 2021 | 37 | 89 | 89 | 52 | -26 |
Q3 2021 | 42 | 88 | 80 | 46 | -21 |
Q4 2021 | 66 | 104 | 62 | 47 | -27 |
Q1 2022 | 58 | 95 | 69 | 65 | -44 |
Hedge funds changes in Mirati Therapeutics stock options (Q2 2017 – Q1 2022)
Q2 2017 | 4,000 | 17,000 |
---|---|---|
Q3 2017 | 2,468,000 | 874,000 |
Q4 2017 | 2,300,000 | 366,000 |
Q1 2018 | 1,311,000 | 1,619,000 |
Q2 2018 | 16,658,000 | 7,449,000 |
Q3 2018 | 33,139,000 | 34,803,000 |
Q4 2018 | 5,297,000 | 2,851,000 |
Q1 2019 | 66,077,000 | 32,567,000 |
Q2 2019 | 213,969,000 | 108,089,000 |
Q3 2019 | 220,897,000 | 159,357,000 |
Q4 2019 | 231,771,000 | 106,601,000 |
Q1 2020 | 111,332,000 | 55,045,000 |
Q2 2020 | 46,787,000 | 66,601,000 |
Q3 2020 | 151,351,000 | 186,522,000 |
Q4 2020 | 231,565,000 | 110,480,000 |
Q1 2021 | 129,167,000 | 87,566,000 |
Q2 2021 | 97,162,000 | 40,707,000 |
Q3 2021 | 260,816,000 | 90,013,000 |
Q4 2021 | 108,244,000 | 53,025,000 |
Q1 2022 | 56,881,000 | 31,575,000 |